Methods Of Treating Retinal Diseases - EP3240612

The patent EP3240612 was granted to Cell Cure Neurosciences on Dec 23, 2020. The application was originally filed on Apr 30, 2015 under application number EP15875361A. The patent is currently recorded with a legal status of "Revoked".

EP3240612

CELL CURE NEUROSCIENCES
Application Number
EP15875361A
Filing Date
Apr 30, 2015
Status
Revoked
Jun 10, 2022
Grant Date
Dec 23, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLESep 23, 2021CARPMAELS & RANSFORDADMISSIBLE
MEISSNER BOLTE PATENTANWALTE RECHTSANWALTE PARTNERSCHAFT MBBSep 22, 2021KILCHERT -

Patent Citations (27) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS3791932
DESCRIPTIONUS3839153
DESCRIPTIONUS3850578
DESCRIPTIONUS3850752
DESCRIPTIONUS3853987
DESCRIPTIONUS3867517
DESCRIPTIONUS3879262
DESCRIPTIONUS3901654
DESCRIPTIONUS3935074
DESCRIPTIONUS3984533
DESCRIPTIONUS3996345
DESCRIPTIONUS4034074
DESCRIPTIONUS4098876
DESCRIPTIONUS4879219
DESCRIPTIONUS5011771
DESCRIPTIONUS5281521
INTERNATIONAL-SEARCH-REPORTWO2013074681
OPPOSITIONEP3240612
OPPOSITIONEP3240892
OPPOSITIONUS2011027333
OPPOSITIONUS8956866
OPPOSITIONWO2013074681
OPPOSITIONWO2014121077
OPPOSITIONWO2016108239
OPPOSITIONWO2016108240
SEARCHUS2013196369
SEARCHWO2015087231

Non-Patent Literature (NPL) Citations (45) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- FRESHNEY, Culture of Animal Cells - A Manual of Basic Technique, Appleton & Lange, (19940000), vol. I-III-
DESCRIPTION- PCR Protocols: A Guide To Methods And Applications, Academic Press, (19900000), vol. 1-317-
DESCRIPTION- STOUTFRANCIS, Human Gene Ther., (20110522), vol. 5, pages 531 - 5-
INTERNATIONAL-SEARCH-REPORT- CLEGG, DENNIS O. et al., "Derivation of retinal pigmented epithelial cells for the treatment of ocular disease.", Stem Cells Handbook., New York, (20130703), pages 411 - 418, URL: http://link.springer.com/chapter/10.1007/978-1-4614-7696-2_29, (20150706), XP055392476 [A] 1-44 * the whole document *
INTERNATIONAL-SEARCH-REPORT- VUGLER, ANTHONY et al., "Elucidating the phenomenon of HESC-derived RPE: anatomy of cell genesis, expansion and retinal transplantation.", Experimental neurology, vol. 214.2, (20080000), pages 347 - 361, URL: http://www.researchgate.net/publication/23389123_Elucidating_the_phenomenon_of_HESC-derived_RPE_anatomy_of_cell_genesis_expansion_and_retinal_transplantation._Exp_Neurol, (20150706), XP025695837 [Y] 1, 2, 5, 18-44 * <DOI: 10.1016/j.expneurol.2008.09.007> 27 Sep 2008 (2008/09/27) Figures 3 and 5, page 359 right column paragraph 7 *
INTERNATIONAL-SEARCH-REPORT- IDELSON, MARIA et al., "Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells.", Cell stem cell, vol. 5.4, pages 396 - 408, URL: http://www.sciencedirect.com/science/article/pii/S1934590909003361, (20150706), XP055046648 [Y] 39-44 * <DOI 10.1016/j.stem.2009.07.002> 02 Oct 2009 (2009/10/02) the whole document, especially abstract, Figures 1-5 *
INTERNATIONAL-SEARCH-REPORT- KAMAO, HIROYUKI et al., "Characterization of human induced pluripotent stem cell -derived retinal pigment epithelium cell sheets aiming for clinical application.", Stem cell reports, vol. 2.2, (20140000), pages 205 - 521, URL: http://www.sciencedirect.com/science/article/pii/52213671113001756, (20150706), XP055144196 [Y] 1, 2, 5, 18-44 * <DOI: 10.1016/j. stemcr.2013.12.007> 23 Jan 2014 (2014/01/23) the whole document, Figures 2B, 2C, last paragraph on page 214 right column *
INTERNATIONAL-SEARCH-REPORT- LUND, RAYMOND D. et al., "Human embryonic stem cell -derived cells rescue visual function in dystrophic RCS rats.", Cloning and stem cells, vol. 8.3, (20060929), pages 189 - 199, URL: http://online.liebertpub.com/doi/abs/10.1089/clo.2006.8.189, (20150706), XP002528361 [Y] 36-38 * the whole document, especially FIG 3, table 1 *
OPPOSITION- Anonymous, "History of Changes for Study: NCT02286089 Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration", Clinicaltrials.gov, (20200212), pages 1 - 5, XP055847644-
OPPOSITION- Anonymous, "History of Changes for Study: NCT02286089 Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration", Clinicaltrials.gov, (20201202), pages 1 - 5, Clinicaltrials.gov, (20211005), XP055847644-
OPPOSITION- Anonymous, "mTeSR™1 Defined, feeder-free maintenance medium for human ES and iPS cells", STEMCELL Technologies, pages 1 - 2-
OPPOSITION- Anonymous, "Press release: Cell Cure Neurosciences Ltd. Provides Update on its Product Development and Partnering Activities", BioTime, (20150217), pages 1 - 3, BioTime, (20211026), XP055854870-
OPPOSITION- Brandl Caroline , Stephanie J Zimmermann, Vladimir M Milenkovic, Sibylle M G Rosendahl, Felix Grassmann, Andrea Milenkovic, Ute Hehr, Marianne Federlin, Christian H Wetzel, Horst Helbig, Bernhard H F Weber, "In-depth characterisation of Retinal Pigment Epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC)", Neuromol Med, (20140000), vol. 16, pages 551 - 564, XP055847574-
OPPOSITION- BRANDL et al., "In-Depth Characterisation of Retinal Pigment Epithelium (RPE) Cells Derived from Human Induced Pluripotent Stem Cells (hiPSC", Neuromolecular Med, (20140000), vol. 16, no. 3, pages 551 - 564, XP055847574-
OPPOSITION- Du Hongjun, Siok Lam Lim, Seanna Grob, Kang Zhang, "Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration", Semin Ophthalmol., (20110500), vol. 26, no. 3, pages 216 - 224, XP055847546-
OPPOSITION- Hanna Vaajasaari; Tanja Ilmarinen; Kati Juuti Uusitalo; Kristiina Rajala; Niina Onnela; Susanna Narkilahti; Riitta Suuronen; Jari Hyttinen; Hannu Uusitalo; Heli Skottman, "Hanna Vaajasaari; Tanja Ilmarinen; Kati Juuti Uusitalo; Kristiina Rajala; Niina Onnela; Susanna Narkilahti; Riitta Suuronen; Jari Hyttinen; Hannu Uusitalo; Heli Skottman", Mol Vis, (20110000), vol. 17, pages 558 - 575, XP055108414-
OPPOSITION- MCGILL et al., "Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation", Transl Vis Sci Technol., (20170000), vol. 6, no. 3, page 17, XP055847603-
OPPOSITION- MCGILL et al., "Long-Term Efficacy of GMP Grade Xeno-Free hESC-Derived RPE Cells Following Transplantation", Trans Vis Sci Tech., (20170000), vol. 6, no. 3, pages 1 - 18, XP055847603-
OPPOSITION- PENG et al., "Engineering a blood-retinal barrier with human embryonic stem cell -derived retinal pigment epithelium: transcriptome and functional analysis", Stem Cells Transl Med, (20130000), vol. 2, no. 7, pages 534 - 544-
OPPOSITION- PRZYBYLA et al., "Probing embryonic stem cell autocrine and paracrine signaling using microfluidics", Annu Rev Anal Chem ( Palo Alto Calif), (20120000), vol. 5, pages 293 - 315, XP055847692-
OPPOSITION- Schwartz Steven D, Et Al, "Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies", Lancet, (20120101), vol. 379, no. 9817, pages 713 - 720, XP055854866-
OPPOSITION- SPERLING L., "Chapter 18", Pluripotent Stem Cells, (20130000), pages 398 - 414, XP055847701-
OPPOSITION- VAAJASAARI et al., "Toward the defined and xeno-free differentiation of functional human pluripotent stem cell -derived retinal pigment epithelial cells", Mol Vis, (20110000), vol. 17, pages 558 - 575, XP055108414-
OPPOSITION- IDELSON et al., "Directed differentiation of human embryonic stem cells into functional retinal pigment epithelium cells", Cell Stem Cell, (20090000), vol. 5, no. 4, doi:10.1016/j.stem.2009.07.002, pages 396 - 408, XP055046648
OPPOSITION- Maria Idelson; Ruslana Alper; Alexey Obolensky; Etti Ben-Shushan; Itzhak Hemo; Nurit Yachimovich-Cohen; Hanita Khaner; Yoav Smith; Ofer Wiser; Michal Gropp; Malkiel A Cohen; Sharona Even-Ram; Yael Berman-Zaken; Limor Matzrafi; Gideon Rechavi; Eyal Banin; Benjamin Reubinoff, "Directed Differentiation of Human Embryonic Stem Cells into Functional Retinal Pigment Epithelium Cells", Cell Stem Cell, (20091002), vol. 5, no. 4, pages 396 - 408, XP055046648
OPPOSITION- Hiroyuki Kamao; Michiko Mandai; Satoshi Okamoto; Noriko Sakai; Akiko Suga; Sunao Sugita; Junichi Kiryu; Masayo Takahashi, "Characterization of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Cell Sheets Aiming for Clinical Application", Stem Cell Reports., (20140000), vol. 2, no. 2, pages 205 - 18, XP055144196
OPPOSITION- SCHWARTZ et al., "Embryonic stem cell trials for macular degeneration: a preliminary report", Lancet, (20120000), vol. 379, no. 9817, doi:10.1016/S0140-6736(12)60028-2, pages 713 - 720, XP055111985
OPPOSITION- Steven D Schwartz; Hubschman Jean-Pierre; Heilwell Gad; Franco-Cardenas Valentina; Pan Carolyn K; Ostrick Rosaleen M; Mickunas Edmund; Gay Roger; Klimanskaya Irina; Lanza Robert, "Embryonic stem cell trials for macular degeneration: a preliminary report", Lancet, (20120000), vol. 379, no. 9817, pages 713 - 720, XP055111985
OPPOSITION- BHARTI et al., "The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells", Pigment Cell Melanoma Res, (20100000), vol. 24, no. 1, doi:10.1111/j.1755-148X.2010.00772.x, pages 21 - 34, XP055116027
OPPOSITION- Kapil Bharti; Sheldon S Miller; Heinz Arnheiter, "The new paradigm: retinal pigment epithelium cells generated from embryonic or induced pluripotent stem cells", Pigment Cell Melanoma Res., (20110000), vol. 24, no. 1, pages 21 - 34, XP055116027
OPPOSITION- MAMINISHKIS et al., "Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue", Invest Ophthalmol Vis Sci., (20060000), vol. 47, no. 8, doi:10.1167/iovs.05-1622, pages 3612 - 3624, XP055453547
OPPOSITION- Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman, "TEER Measurement Techniques for In Vitro Barrier Model Systems", J Lab Autom, (20150000), vol. 20, no. 2, pages 107 - 126, XP055560328
OPPOSITION- CARR et al., "Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat", PLoS One, (20090000), vol. 4, no. 12, doi:10.1371/journal.pone.0008152, page e8152, XP055070946
OPPOSITION- Shelly E Tannenbaum; Tikva Tako Turetsky; Orna Singer; Einat Aizenman; Sophie Kirshberg; Nili Ilouz; Yaniv Gil; Yael Berman-Zaken; Temima Schnitzer Perlman; Nitshia Geva; Ora Levy; Daniel Arbell; Alex Simon; Assaf Ben-Meir; Yoel Shufaro; Neri Laufer; Benjamin E Reubinoff, "Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells - Platforms for Future Clinical Applications", PLoS One, (20120000), vol. 7, no. 6, pages 1 - 16, XP055471292
OPPOSITION- TANNENBAUM et al., "Derivation of xeno-free and GMP-grade human embryonic stem cells - platforms for future clinical applications", PLoS One, (20120000), vol. 7, no. 6, doi:10.1371/journal.pone.0035325, page e35325, XP055471292
OPPOSITION- Yu Zhu; Madalena Carido; Andrea Meinhardt; Thomas Kurth; Mike O Karl; Marius Ader; Elly M Tanaka, "Three-Dimensional Neuroepithelial Culture from Human Embryonic Stem Cells and Its Use for Quantitative Conversion to Retinal Pigment Epithelium", PLoS One, (20130000), vol. 8, no. 1, pages 1 - 13, XP055332448
OPPOSITION- BUZHOR et al., "Cell -based therapy approaches: the hope for incurable diseases", Regen Med, (20140000), vol. 9, no. 5, doi:10.2217/rme.14.35, pages 649 - 672, XP009188959
OPPOSITION- Krohne T U; Westenskow P D; Kurihara T; Friedlander D F; Lehmann M; Dorsey A L; Li W; Zhu S; Schultz A; Wang J; Siuzdak G; Ding S; Friedlander M, "Generation of Retinal Pigment Epithelial Cells from Small Molecules and OCT4 Reprogrammed Human Induced Pluripotent Stem Cells", Stem Cells Translational Medicine, (20120000), vol. 1, no. 2, pages 96 - 109, XP055121499
OPPOSITION- MARUOTTI et al., "A Simple and Scalable Process for the Differentiation of Retinal Pigment Epithelium From Human Pluripotent Stem Cells", Stem Cells Translational Medicine, (20130000), vol. 2, no. 5, pages 341 - 354, XP002794364
OPPOSITION- BUCHHOLZ et al., "Rapid and Efficient Directed Differentiation of Human Pluripotent Stem Cells Into Retinal Pigmented Epithelium", Stem Cells Translational Medicine, (20130000), vol. 2, no. 5, pages 384 - 393, XP055114659
OPPOSITION- Lane A; Philip L R; Ruban L; Fynes K; Smart M; Carr A; Mason C; Coffey P, "Engineering Efficient Retinal Pigment Epithelium Differentiation From Human Pluripotent Stem Cells", Stem Cells Transl Med, (20140000), vol. 3, no. 11, pages 1295 - 1304, XP055303892
OPPOSITION- PENNINGTON et al., "Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate", Stem Cells Transl Med, (20150000), vol. 4, no. 2, doi:10.5966/sctm.2014-0179, pages 165 - 177, XP055378623
SEARCH- HANNA VAAJASAARI ET AL, "Toward the defined and xeno-free differentiation of functional human pluripotent stem cell-derived retinal pigment epithelial cells.", MOLECULAR VISION, (20110101), vol. 17, ISSN 1090-0535, pages 558 - 575, XP055108414 [Y] 1,2,4,8-20 * page 562, column l, paragraph 2 * * page 569, paragraph l - page 570, paragraph 1 *-
SEARCH- SHELLY E. TANNENBAUM ET AL, "Derivation of Xeno-Free and GMP-Grade Human Embryonic Stem Cells - Platforms for Future Clinical Applications", PLOS ONE, (20120620), vol. 7, no. 6, doi:10.1371/journal.pone.0035325, page e35325, XP055471292 [A] 1-20 * figure 3 *
SEARCH- BUZHOR ELLA ET AL, "Cell-based therapy approaches: the hope for incurable diseases", REGENERATIVE MEDICINE, FUTURE MEDICINE, UK, (20140101), vol. 9, no. 5, doi:10.2217/RME.14.35, ISSN 1746-076X, pages 649 - 672, XP009188959 [Y] 1,2,4,8-20 * page 656, column r, paragraph 3 - page 657, column l, paragraph 2 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents